Identifying Undisclosed Related Party Transactions Through Prospectus Footnote Analysis

The SFC’s 2024 enforcement report recorded 13 cases involving false or misleading financial information in listing documents, a 44% increase from the nine cases in 2023. This surge coincides with the HKEX’s 2025 push to fast-track IPOs for high-growth enterprises under Chapter 18C, where reduced track-record requirements inherently lower the bar for financial disclosure scrutiny. For sponsors and underwriters, the most frequently missed red flag is not in the audited financial statements but in the footnotes—specifically, the related party transaction (RPT) disclosures. Under HKEX Listing Rule 14A, RPTs exceeding 0.1% of the applicable percentage ratios require disclosure, yet a 2023 HKMA circular on trade finance fraud highlighted that 62% of investigated cases involved undisclosed RPTs structured through offshore intermediaries in BVI or Cayman. This article provides a systematic methodology for identifying undisclosed RPTs through prospectus footnote analysis, drawing on real HKEX enforcement actions and SFC disciplinary outcomes from 2022-2025.

The Footnote as a Forensic Document

The prospectus footnote section—particularly notes 24 to 32 covering related parties under HKAS 24—is the single most concentrated source of undisclosed RPT indicators. HKAS 24 requires disclosure of all transactions with related parties, regardless of whether a price was charged, but the standard permits aggregation of similar items. This aggregation is the primary concealment mechanism.

The Aggregation Trap in HKAS 24 Compliance

HKEX Listing Rule 14A.33 requires that RPTs be disclosed individually if they exceed HK$1,000,000 or 0.1% of the relevant percentage ratio, whichever is lower. In practice, issuers aggregate multiple small transactions with the same counterparty to stay below this threshold. The 2024 SFC disciplinary action against ABCI Capital Limited (a sponsor) cited this exact pattern: the sponsor failed to identify that 17 separate consultancy payments to a BVI-registered entity, each below HK$800,000, aggregated to HK$12.6 million—triggering a discloseable RPT under Rule 14A.34.

Analysts should compare the total “other payables” figure in the balance sheet (note 17) against the disclosed RPT amounts in note 28. A variance exceeding 15% warrants a flagged query. In the 2023 prospectus of a GEM-listed construction firm, note 17 showed HK$45.2 million in other payables, but note 28 disclosed only HK$8.1 million in RPT payables. The HK$37.1 million gap was later traced to undisclosed advances to a director’s family trust in Bermuda.

The Zero-Balance Trap

A common concealment technique is to structure RPTs as fully settled within the same financial period, resulting in a zero balance at year-end. Under HKAS 24.18, entities must disclose the nature of the relationship, the transaction amount, and any outstanding balances—but zero balances are not specifically prohibited from omission. The SFC’s 2022 enforcement against a Main Board-listed pharmaceutical company demonstrated this: the issuer disclosed HK$0 in RPT payables for three consecutive years, yet the sponsor’s working capital audit revealed HK$23.4 million in monthly payments to a Cayman entity with the same registered address as the founder’s private investment vehicle.

The forensic indicator here is the cash flow statement. Note 22 (cash flow from operating activities) will show “other operating payments” or “advances to third parties.” If this line item exceeds 20% of revenue while RPT disclosures are minimal, the probability of undisclosed RPTs exceeds 70% based on SFC’s 2023 thematic review of 40 prospectuses.

Cross-Referencing the Director and Shareholder Register

The most effective cross-reference is between the director and senior management register (note 25) and the list of top 10 customers and suppliers (note 32). HKEX Listing Rule 14A.09 defines a related party as including any person who has been a director or substantial shareholder in the 12 months preceding the listing. This creates a lookback window that many issuers ignore.

The 12-Month Lookback in Practice

In the 2024 prospectus of a PRC-based e-commerce platform, note 25 listed 12 directors and supervisors. The top five suppliers in note 32 included a company registered in the Marshall Islands that had been a customer for only six months. Cross-referencing the director register against the Marshall Islands company’s beneficial ownership—using the HKEX’s enhanced disclosure requirements under Rule 18.05—revealed that the Marshall Islands entity was 100% owned by the brother of a former director who had resigned 11 months before the listing application. This relationship was not disclosed as an RPT.

The SFC’s 2025 consultation paper on sponsor liability specifically targets this gap, proposing that sponsors must conduct a 24-month lookback for RPT identification. Until this becomes a formal rule, analysts should manually extend the lookback period to 24 months when reviewing prospectuses filed under Chapter 18C, where the track record is only 12 months.

The Subsidiary and Associate Network

HKAS 24.9 requires disclosure of transactions with subsidiaries, associates, and joint ventures—even if they are fully consolidated. The concealment pattern is to use a subsidiary that is dormant or has minimal operations as a conduit for RPTs. In the 2023 prospectus of a Shenzhen-based semiconductor company, note 30 listed 14 subsidiaries, of which 7 had zero revenue and zero employees. The cash flow statement showed HK$18.7 million in “inter-company transfers” to these dormant entities. The sponsor’s due diligence failed to trace these transfers to the personal accounts of two controlling shareholders, who used the dormant subsidiaries to purchase luxury assets.

The analytical method is to compare the “investment in subsidiaries” line (note 14) against the “amounts due from subsidiaries” line (note 17). If the latter exceeds the former by more than 50%, and the subsidiaries have no revenue, the probability of undisclosed RPTs is high. In the semiconductor case, the ratio was 3.2x—HK$12.4 million in investment versus HK$39.8 million in amounts due.

Cash Flow Statement Anomalies as RPT Proxies

The cash flow statement is the least scrutinised primary financial statement in prospectus analysis, yet it provides the most direct evidence of undisclosed RPTs. Under HKAS 7, cash flows must be classified as operating, investing, or financing. RPTs are most commonly misclassified as operating cash flows to avoid disclosure in the investing or financing sections, which have stricter RPT disclosure requirements under HKEX Listing Rule 14A.52.

The “Other Operating Payments” Red Flag

The line item “other operating payments” in the cash flow from operating activities section is a catch-all category. In the 2024 prospectus of a Macau-based gaming technology firm, other operating payments represented 34% of total operating cash outflows, or HK$127.8 million. The prospectus notes disclosed only HK$3.2 million in RPTs. The SFC’s subsequent investigation found that HK$89.4 million of these payments were made to a BVI entity controlled by the CEO’s spouse, structured as “technology licensing fees” with no formal agreement.

The benchmark is simple: if other operating payments exceed 15% of revenue and the disclosed RPT amount is less than 1% of revenue, the gap must be explained. In the SFC’s 2023 thematic review, 8 of 12 prospectuses with this ratio had material undisclosed RPTs.

The “Advances to Suppliers” Mismatch

Many issuers classify RPTs as “advances to suppliers” in the cash flow statement. The forensic test is to cross-reference the “advances to suppliers” line against the “trade and other payables” note. If advances to suppliers exceed trade payables by more than 25%, and the top suppliers are not disclosed in note 32, the advances likely represent RPTs.

In the 2025 prospectus of a Hong Kong-listed logistics company (Main Board), advances to suppliers of HK$56.2 million were 2.1x the trade payables of HK$26.8 million. The top five suppliers in note 32 accounted for only HK$18.4 million of total purchases. The HK$37.8 million gap was traced to a Cayman entity that was the sole supplier of IT services, but the entity was owned by the CFO’s father. This RPT was not disclosed in note 28.

The Offshore Entity Network Mapping

The most sophisticated undisclosed RPT structures involve a network of offshore entities in multiple jurisdictions. Hong Kong issuers commonly use BVI, Cayman, and Bermuda entities for legitimate corporate structuring, but these same jurisdictions are used to obscure RPTs. The HKEX’s 2024 Guidance Letter GL117-24 specifically requires issuers to disclose the jurisdiction of incorporation for all material subsidiaries and significant counterparties.

The Jurisdiction Concentration Indicator

If an issuer’s top five customers or suppliers are incorporated in a single offshore jurisdiction with no physical presence or business operations in that jurisdiction, the probability of undisclosed RPTs is high. In the 2023 prospectus of a PRC-based chemical manufacturer, four of the top five suppliers were BVI companies with registered addresses at the same service provider in Road Town, Tortola. The prospectus disclosed zero RPTs with these suppliers. The SFC’s enforcement action found that all four BVI entities were beneficially owned by the issuer’s controlling shareholder, who used them to inflate raw material costs by an average of 23%.

The analytical method is to map the jurisdiction of incorporation for all counterparties disclosed in note 32. If more than 30% of counterparties are from a single offshore jurisdiction, and the issuer’s own corporate structure does not have a comparable concentration, the RPT disclosure should be treated as incomplete.

The Registered Agent Overlap

A more granular indicator is the registered agent or registered address overlap between the issuer’s offshore subsidiaries and its counterparties. In the 2024 prospectus of a Hong Kong-listed financial services firm, the issuer’s BVI subsidiary and its top three customers all used the same registered agent in the Cayman Islands. The agent’s records, obtained through the SFC’s statutory powers under the Securities and Futures Ordinance (Cap. 571), Section 183, revealed that all three customers were ultimately controlled by the issuer’s executive director.

This overlap is not illegal per se, but it creates a rebuttable presumption of RPT existence. Under HKEX Listing Rule 14A.70, the burden of proof shifts to the issuer to demonstrate that no RPT exists when such overlaps are present. Analysts should flag any prospectus where the registered agent of a significant counterparty matches the agent of the issuer or any of its subsidiaries.

Actionable Takeaways for Prospectus Review

1. Compare the “other payables” balance in note 17 against disclosed RPT payables in note 28; a variance exceeding 15% requires a written explanation from the sponsor under HKEX Listing Rule 14A.34.
2. Extend the RPT lookback period to 24 months for Chapter 18C applicants, as the SFC’s 2025 consultation paper proposes this standard for sponsor liability.
3. Cross-reference the “other operating payments” line in the cash flow statement against disclosed RPT amounts; if the ratio exceeds 15% of revenue to 1% of revenue, flag for SFC enquiry.
4. Map the jurisdiction of incorporation for all top five customers and suppliers; a concentration exceeding 30% in a single offshore jurisdiction with no operational presence creates a rebuttable presumption of undisclosed RPTs.
5. Verify that all dormant subsidiaries with zero revenue but material inter-company transfers have been disclosed as RPT counterparties under HKAS 24.9, and request the sponsor’s working papers for any subsidiary where amounts due exceed investment by more than 50%.